Request for Information D- -Diversion Control Divisions Information Technology Systems

Request for Information (RFI) – Enterprise Modernization of the Drug Enforcement Administration Diversion Control Division’s (DC) Information Technology (IT) Systems

1. Overview

The Drug Enforcement Administration (DEA), a component of the U.S. Department of Justice (DOJ), is conducting market research to identify a modern solution, such as SaaS and COTS, to facilitate the Diversion Control Division’s (DC) transformation of decentralized, siloed applications. Solutions must provide DEA with centralized, secure, and easily scalable capabilities.
This Request for Information (RFI) is issued solely for information gathering and acquisition planning under FAR 15.201(e) and does not constitute a solicitation. The DEA is seeking industry feedback on single sign-on (SSO) solutions that can provide a secure, scalable, compliant, and modern platform that improves operational efficiency, data quality, interoperability, cybersecurity, and mission support. The desired solution should also provide a flexible foundation for automation, analytics, mobile access, and future capabilities.
Interested parties are encouraged to describe their solution approach, implementation strategy, relevant federal experience, technical architecture, artificial intelligence capabilities, security and compliance capabilities, performance measures, and available ordering vehicles that may be leveraged.

2. Background and Mission Need

DEA’s Diversion Control Division (DC) serves as the regulatory and enforcement authority responsible for preventing, detecting, and investigating the diversion of pharmaceutical controlled substances and listed chemicals while ensuring an adequate and uninterrupted supply for legitimate medical, scientific, and commercial purposes. In support of this mission, DEA acts as the central authority for issuing registrations that authorize the handling of controlled substances and listed chemicals for approximately 2.2 million registrants. The Diversion Control program also:
•
•
•
•

Enables vital data sharing with internal and external partners Supports enforcement of the Controlled Substances Act (CSA) through criminal, civil, and administrative actions
Establishes national drug production quotas for domestic and international use Automates monitoring and tracking of the distribution of certain controlled substances

•
•

Oversees the importation and exportation of controlled substances and listed chemicals
Performs activities related to drug scheduling and compliance with international